期刊
BIOLOGICAL CHEMISTRY
卷 399, 期 9, 页码 1023-1039出版社
WALTER DE GRUYTER GMBH
DOI: 10.1515/hsz-2018-0001
关键词
bladder cancer; microenvironment proteinases; multiple sclerosis; prostate cancer; proteinase-activated receptors (PARs); T-cells/macrophages/splenocytes
资金
- Johnson & Johnson Alberta Health Innovation Partnership (JAHIP) Prostate Cancer Research Fund/University Hospital Foundation, University of Alberta Hospital
- Canadian Institutes of Health Research [201603PJT-363434-PJT-CBBA-13135]
We propose that in the microenvironment of inflammatory tissues, including tumours, extracellular proteinases can modulate cell signalling in part by regulating proteinase-activated receptors (PARs). We have been exploring this mechanism in a variety of inflammation and tumour-related settings that include tumour-derived cultured cells from prostate and bladder cancer, as well as immune inflammatory cells that are involved in the pathology of inflammatory diseases including multiple sclerosis. Our work showed that proteinase signalling via the PARs affects prostate and bladder cancer-derived tumour cell behaviour and can regulate calcium signalling in human T-cell and macrophage-related inflammatory cells as well as in murine splenocytes. Further, we found that the tumour-derived prostate cancer cells and immune-related cells (Jurkat, THP1, mouse splenocytes) can produce PAR-regulating proteinases (including kallikreins: kallikrein-related peptidases), that can control tissue function by both a paracrine and autocrine mechanism. We suggest that this PAR-driven signalling process involving secreted microenvironment proteinases can play a key role in cancer and inflammatory diseases including multiple sclerosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据